MedPath

Effect of Angiotensin-converting enzyme and ß-blockers on the prognosis of severe isolated brain trauma

Phase 3
Conditions
S06.2X
Severe isolated brain trauma.
Diffuse traumatic brain injury
Registration Number
IRCT20210514051289N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
96
Inclusion Criteria

Severe trauma
Age greater than or equal to 18 years
No previous use of beta-blockers or Angiotensin-converting enzyme at home
Informed consent of the patient's guardian or legal guardian to admit the patient to the study

Exclusion Criteria

Renal artery stenosis
Chronic kidney disease
History of drug allergy
Hyperkalemia
High creatinine
Bradycardia or heart block

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glasgow Outcome Score. Timepoint: Three months after the intervention. Method of measurement: Glasgow Outcome Scale to measure level of consciousness.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath